BIOMAT Database Logo BIOMAT Database Logo

[Possibilities in the determination of kidney concentrating ability as based on the DDAVP [deamino-(8-D-arginine)-vasopressin] test]. 1978

H Nádvorníková, and O Schück, and J H Cort

UI MeSH Term Description Entries
D007671 Kidney Concentrating Ability The ability of the kidney to excrete in the urine high concentrations of solutes from the blood plasma. Urine Concentrating Ability,Abilities, Kidney Concentrating,Abilities, Urine Concentrating,Ability, Kidney Concentrating,Ability, Urine Concentrating,Concentrating Abilities, Kidney,Concentrating Abilities, Urine,Concentrating Ability, Kidney,Concentrating Ability, Urine,Kidney Concentrating Abilities,Urine Concentrating Abilities
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003894 Deamino Arginine Vasopressin A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR. Desmopressin,Vasopressin, Deamino Arginine,1-Deamino-8-D-arginine Vasopressin,1-Desamino-8-arginine Vasopressin,Adiuretin,Adiuretin SD,Apo-Desmopressin,DDAVP,Desmogalen,Desmopressin Acetate,Desmopressin Monoacetate,Desmopressin Monoacetate, Trihydrate,Desmopressine Ferring,Desmospray,Desmotabs,Minirin,Minurin,Nocutil,Octim,Octostim,Acetate, Desmopressin,Arginine Vasopressin, Deamino,Ferring, Desmopressine,Monoacetate, Desmopressin,Monoacetate, Trihydrate Desmopressin,Trihydrate Desmopressin Monoacetate,Vasopressin, 1-Deamino-8-D-arginine,Vasopressin, 1-Desamino-8-arginine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Nádvorníková, and O Schück, and J H Cort
The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
April 1976, International journal of clinical pharmacology and biopharmacy,
H Nádvorníková, and O Schück, and J H Cort
[Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time in uremic patients].
August 1985, Revista medica de Chile,
H Nádvorníková, and O Schück, and J H Cort
1-desamino-8-D-arginine vasopressin (DDAVP) concentration test.
January 1978, The American journal of the medical sciences,
H Nádvorníková, and O Schück, and J H Cort
Production of porcine antibodies with high specificity to [8-D-arginine] deamino-vasopressin (dDAVP).
December 1977, Experientia,
H Nádvorníková, and O Schück, and J H Cort
[DDAVP loading test (a test on kidney concentrating ability)].
June 1979, Nihon rinsho. Japanese journal of clinical medicine,
H Nádvorníková, and O Schück, and J H Cort
Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
June 1976, Journal of medicinal chemistry,
H Nádvorníková, and O Schück, and J H Cort
[Urine concentrating ability test with the vasopressin analog DDAVP].
May 1979, Lakartidningen,
H Nádvorníková, and O Schück, and J H Cort
DDAVP (desmopressin; 1-deamino-cys-8-D-arginine-vasopressin) treatment in children with haemophilia B.
December 2000, British journal of haematology,
H Nádvorníková, and O Schück, and J H Cort
[DDAVP (1-desamino-8-D-arginine vasopressin )].
November 1989, Ugeskrift for laeger,
H Nádvorníková, and O Schück, and J H Cort
[Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
July 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!